HU9200461D0 - Method for producing 5-(1-amino-cyclohexyl)-2(1h)-pyridinone derivatives - Google Patents

Method for producing 5-(1-amino-cyclohexyl)-2(1h)-pyridinone derivatives

Info

Publication number
HU9200461D0
HU9200461D0 HU9200461A HU46190A HU9200461D0 HU 9200461 D0 HU9200461 D0 HU 9200461D0 HU 9200461 A HU9200461 A HU 9200461A HU 46190 A HU46190 A HU 46190A HU 9200461 D0 HU9200461 D0 HU 9200461D0
Authority
HU
Hungary
Prior art keywords
image
loweralkyl
hydrogen
cyclohexyl
amino
Prior art date
Application number
HU9200461A
Other languages
English (en)
Inventor
Richard Charles Effland
David M Fink
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of HU9200461D0 publication Critical patent/HU9200461D0/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU9200461A 1989-08-16 1990-08-16 Method for producing 5-(1-amino-cyclohexyl)-2(1h)-pyridinone derivatives HU9200461D0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/394,448 US4978663A (en) 1989-08-16 1989-08-16 5-(1-aminocyclohexyl)-2(1H)-pyridinone compounds which have pharmaceutical utility

Publications (1)

Publication Number Publication Date
HU9200461D0 true HU9200461D0 (en) 1992-05-28

Family

ID=23558997

Family Applications (2)

Application Number Title Priority Date Filing Date
HU9200461A HUT67589A (en) 1989-08-16 1990-08-16 Process for producing 5-(1-aminocycloxyl)-2(1h)-pyridinone derivatives and pharmaceutical compositions comprising them
HU9200461A HU9200461D0 (en) 1989-08-16 1990-08-16 Method for producing 5-(1-amino-cyclohexyl)-2(1h)-pyridinone derivatives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HU9200461A HUT67589A (en) 1989-08-16 1990-08-16 Process for producing 5-(1-aminocycloxyl)-2(1h)-pyridinone derivatives and pharmaceutical compositions comprising them

Country Status (14)

Country Link
US (1) US4978663A (hu)
EP (1) EP0487602B1 (hu)
JP (3) JP2557568B2 (hu)
KR (1) KR927003532A (hu)
AT (1) ATE155458T1 (hu)
AU (1) AU652126B2 (hu)
CA (2) CA2332188C (hu)
DE (1) DE69031075T2 (hu)
DK (1) DK0487602T3 (hu)
ES (1) ES2109239T3 (hu)
FI (1) FI920637A0 (hu)
HU (2) HUT67589A (hu)
NO (1) NO920600L (hu)
WO (1) WO1991002721A1 (hu)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW473479B (en) 1997-12-19 2002-01-21 Takeda Chemical Industries Ltd Phosphonocephem derivatives, their production and use
TWI417095B (zh) 2006-03-15 2013-12-01 Janssen Pharmaceuticals Inc １，４-二取代之３-氰基-吡啶酮衍生物及其作為ｍＧｌｕＲ２-受體之正向異位性調節劑之用途
TW200845978A (en) * 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
EP2200985B1 (en) 2007-09-14 2011-07-13 Ortho-McNeil-Janssen Pharmaceuticals, Inc. 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
CN101801951B (zh) 2007-09-14 2013-11-13 杨森制药有限公司 1’,3’-二取代的-4-苯基-3,4,5,6-四氢-2h,1’h-[1,4’]二吡啶-2’-酮
AU2008297877C1 (en) * 2007-09-14 2013-11-07 Addex Pharma S.A. 1,3-disubstituted-4-phenyl-1 H-pyridin-2-ones
CN101861316B (zh) * 2007-11-14 2013-08-21 奥梅-杨森制药有限公司 咪唑并[1,2-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
ES2439291T3 (es) 2008-09-02 2014-01-22 Janssen Pharmaceuticals, Inc. Derivados de 3-azabiciclo[3.1.0]hexilo como moduladores de receptores de glutamato metabotrópicos
JP5656848B2 (ja) 2008-10-16 2015-01-21 ジャンセン ファーマシューティカルズ， インコーポレイテッド． 代謝型グルタミン酸受容体モジュレーターとしてのインドールおよびベンゾモルホリンの誘導体
US8691813B2 (en) 2008-11-28 2014-04-08 Janssen Pharmaceuticals, Inc. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
MX2011011962A (es) 2009-05-12 2012-02-28 Janssen Pharmaceuticals Inc Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostericos positivos de receptores de glutamato metabotropico (mglur2).
ME01573B (me) 2009-05-12 2014-09-20 Addex Pharma Sa DERIVATI 1,2,4-TRIAZOLO[4,3-a]PIRIDINA I NJIHOVA UPOTREBA U TRETMANU ILI PREVENCIJI NEUROLOŠKIH I PSIHIJATRIJSKIH POREMEĆAJA
US9271967B2 (en) 2010-11-08 2016-03-01 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
AU2011328195B2 (en) 2010-11-08 2015-04-02 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
JP5852666B2 (ja) 2010-11-08 2016-02-03 ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド １，２，４−トリアゾロ［４，３−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
PL3096790T3 (pl) 2014-01-21 2020-01-31 Janssen Pharmaceutica, N.V. Kombinacje zawierające pozytywne modulatory allosteryczne lub agonistów ortosterycznych metabotropowego receptora glutaminergicznego podtypu 2 i ich zastosowanie
KR20200036063A (ko) 2014-01-21 2020-04-06 얀센 파마슈티카 엔.브이. 대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
CN112409266A (zh) * 2019-08-22 2021-02-26 江苏阿尔法药业有限公司 一种索菲布韦中间体及其制备方法
CN112409267A (zh) * 2019-08-22 2021-02-26 江苏阿尔法药业有限公司 一种索菲布韦中间体的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA903224A (en) * 1972-06-20 F. Czaja Robert Process for the production of pyridones
GB851577A (en) * 1958-03-06 1960-10-19 Parke Davis & Co Pyridine compounds and methods for producing the same
US3655897A (en) * 1971-01-25 1972-04-11 Merck & Co Inc Anti-inflammatory agents
JPS61165372A (ja) * 1985-01-17 1986-07-26 Daicel Chem Ind Ltd ５−ハロピリジン−３−カルボキサミド化合物
DE3823991A1 (de) * 1988-07-15 1990-02-15 Basf Ag Heterocyclisch substituierte (alpha)-aryl-acrylsaeureester und fungizide, die diese verbindungen enthalten

Also Published As

Publication number Publication date
JP2708736B2 (ja) 1998-02-04
CA2332188C (en) 2007-01-23
HUT67589A (en) 1995-04-28
JP2708737B2 (ja) 1998-02-04
DK0487602T3 (da) 1998-02-09
EP0487602B1 (en) 1997-07-16
US4978663A (en) 1990-12-18
CA2063594C (en) 2002-07-16
JPH09100287A (ja) 1997-04-15
FI920637A0 (fi) 1992-02-14
DE69031075T2 (de) 1998-02-26
CA2063594A1 (en) 1991-02-17
ATE155458T1 (de) 1997-08-15
AU652126B2 (en) 1994-08-18
CA2332188A1 (en) 1991-02-17
JP2557568B2 (ja) 1996-11-27
KR927003532A (ko) 1992-12-18
JPH04507421A (ja) 1992-12-24
NO920600L (no) 1992-04-14
EP0487602A4 (en) 1993-03-17
EP0487602A1 (en) 1992-06-03
JPH09100288A (ja) 1997-04-15
ES2109239T3 (es) 1998-01-16
DE69031075D1 (de) 1997-08-21
AU6284290A (en) 1991-04-03
WO1991002721A1 (en) 1991-03-07
NO920600D0 (no) 1992-02-14

Similar Documents

Publication Publication Date Title
HU9200461D0 (en) Method for producing 5-(1-amino-cyclohexyl)-2(1h)-pyridinone derivatives
HU911771D0 (en) Process for producing substituted and heterocyclic phthalides
ES8106723A1 (es) Un metodo para la preparacion de derivados de ftalimidina
HU9203761D0 (en) Method for producing substituted pyridine derivatives
PL328789A1 (en) Novel heterocyclic compounds, method of obtaining them, their application in production of a pharmaceutic agent and pharmaceutic agent obtained thereby
HU912450D0 (en) Process for producing 1-(substituted pyridinyl-amino)-1h-indole-5h-yl substituted carbamates and pharmaceutical preparatives containing said compounds
IL84564A (en) Fused heterocyclic tetrahydroamino- quinolinols and related compounds, a process for their preparation and pharmaceutical compositions containing them
HUT42277A (en) Herbicides containing as active subtance derivatives of new 1-aryl-4-nitro-pirasole and process for production of the active substances
PT92234A (pt) Processo para a preparacao de 1,2,3,4-tetraidro-1,9-acridinodiaminas
HU912540D0 (en) Process for the production of insecticide, akaricide and nematicide 2-aryl-5-(trifluor-methyl)-pyrrole derivatives
PL291408A1 (en) Method of obtaining novel 1-(pyridinylalkylo)-1h-indoles
NO911998L (no) Pyrido(3,4-b)(pyrrolo(1,2-e)(1,4,5)oksadiazepin og beslektede analoger og fremgangsmaate for fremstilling derav.
NO902556D0 (no) 4,5,5a,6-tetrahydro-3h-isoksazol(5,4,3-kl)akridinderivater og fremgangsmaate for fremstilling derav.
HUT34316A (en) Process for producing heterocyclic hydroximidates and thiohydroximidates and their carbamate-ester derivatives
ZA832824B (en) New therapeutically useful dithiino (1,4)(2,3-c)pyrrole derivatives